Safety issues with drug therapies for autism spectrum disorders - PubMed (original) (raw)
Affiliations
- PMID: 16401148
Review
Safety issues with drug therapies for autism spectrum disorders
James T McCracken. J Clin Psychiatry. 2005.
Abstract
Although currently no medication has been approved to treat autism spectrum disorders, survey data show that community practitioners are prescribing a broad range of medication treatments, including, but not limited to, antidepressants, stimulants, antipsychotics, alpha agonists, and anticonvulsants. Patients with autism spectrum disorders are also taking alternative treatments, including herbal remedies, immunologic treatments, and vitamin therapies, which may themselves produce side effects and/or create drug interactions with traditional medications. Although short-term data on the efficacy and safety of commonly prescribed treatments for autism spectrum disorders are increasing, few data are currently available on long-term treatment for autism spectrum disorders, but available studies and clinical experience can offer preliminary recommendations on the safety of and monitoring needs for the medications currently used for these disorders. Monitoring the safety and tolerability of drugs used in patients with these disorders should minimize the burden of side effects and optimize treatment outcome.
Similar articles
- Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
Findling RL. Findling RL. J Clin Psychiatry. 2005;66 Suppl 10:26-31. J Clin Psychiatry. 2005. PMID: 16401147 Review. - Treatments for late-life bipolar disorder.
Aziz R, Lorberg B, Tampi RR. Aziz R, et al. Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. doi: 10.1016/j.amjopharm.2006.12.007. Am J Geriatr Pharmacother. 2006. PMID: 17296540 Review. - Pharmacologic treatment of pediatric insomnia.
Owens JA, Moturi S. Owens JA, et al. Child Adolesc Psychiatr Clin N Am. 2009 Oct;18(4):1001-16. doi: 10.1016/j.chc.2009.04.009. Child Adolesc Psychiatr Clin N Am. 2009. PMID: 19836701 Review. - Managing irritability and aggression in autism spectrum disorders in children and adolescents.
Robb AS. Robb AS. Dev Disabil Res Rev. 2010;16(3):258-64. doi: 10.1002/ddrr.118. Dev Disabil Res Rev. 2010. PMID: 20981764 Review. - An update on pharmacologic treatments for autism spectrum disorders.
King BH, Bostic JQ. King BH, et al. Child Adolesc Psychiatr Clin N Am. 2006 Jan;15(1):161-75. doi: 10.1016/j.chc.2005.08.005. Child Adolesc Psychiatr Clin N Am. 2006. PMID: 16321729 Review.
Cited by
- Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B. Aman M, et al. J Child Adolesc Psychopharmacol. 2015 Aug;25(6):482-93. doi: 10.1089/cap.2015.0005. J Child Adolesc Psychopharmacol. 2015. PMID: 26262903 Free PMC article. Clinical Trial. - Perspectives on the use of stem cells for autism treatment.
Siniscalco D, Bradstreet JJ, Sych N, Antonucci N. Siniscalco D, et al. Stem Cells Int. 2013;2013:262438. doi: 10.1155/2013/262438. Epub 2013 Oct 10. Stem Cells Int. 2013. PMID: 24222772 Free PMC article. Review. - Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders.
De Nadai AS, Storch EA, McGuire JF, Lewin AB, Murphy TK. De Nadai AS, et al. J Cent Nerv Syst Dis. 2011 Jun 1;3:125-42. doi: 10.4137/JCNSD.S6616. Print 2011. J Cent Nerv Syst Dis. 2011. PMID: 23861643 Free PMC article. - Coping, fostering resilience, and driving care innovation for autistic people and their families during the COVID-19 pandemic and beyond.
Ameis SH, Lai MC, Mulsant BH, Szatmari P. Ameis SH, et al. Mol Autism. 2020 Jul 22;11(1):61. doi: 10.1186/s13229-020-00365-y. Mol Autism. 2020. PMID: 32698850 Free PMC article. - [Psychopharmacology of autism spectrum disorders].
Poustka L, Banaschewski T, Poustka F. Poustka L, et al. Nervenarzt. 2011 May;82(5):582-9. doi: 10.1007/s00115-010-3238-7. Nervenarzt. 2011. PMID: 21484169 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical